Neil Nancy, Inglese Gary, Manson Andrea, Townshend Arden
Nancy Neil, PhD, Chordata Consulting, LLC, Tacoma, Washington.Gary Inglese, RN, Hollister Incorporated, Libertyville, Illinois.Andrea Manson, BSN, RN, ET, Ostomy Care and Supply Centre, New Westminster, British Columbia, Canada.Arden Townshend, BSN, RN, ET, Ostomy Care and Supply Centre, New Westminster, British Columbia, Canada.
J Wound Ostomy Continence Nurs. 2016 Jan-Feb;43(1):62-8. doi: 10.1097/WON.0000000000000194.
The aim of this study was to evaluate the economic and humanistic implications of using ostomy components to prevent subsequent peristomal skin complications (PSCs) in individuals who experience an initial, leakage-related PSC event.
Cost-utility analysis.
We developed a simple decision model to consider, from a payer's perspective, PSCs managed with and without the use of ostomy components over 1 year. The model evaluated the extent to which outcomes associated with the use of ostomy components (PSC events avoided; quality-adjusted life days gained) offset the costs associated with their use.
Our base case analysis of 1000 hypothetical individuals over 1 year assumes that using ostomy components following a first PSC reduces recurrent events versus PSC management without components. In this analysis, component acquisition costs were largely offset by lower resource use for ostomy supplies (barriers; pouches) and lower clinical utilization to manage PSCs. The overall annual average resource use for individuals using components was about 6.3% ($139) higher versus individuals not using components. Each PSC event avoided yielded, on average, 8 additional quality-adjusted life days over 1 year.
In our analysis, (1) acquisition costs for ostomy components were offset in whole or in part by the use of fewer ostomy supplies to manage PSCs and (2) use of ostomy components to prevent PSCs produced better outcomes (fewer repeat PSC events; more health-related quality-adjusted life days) over 1 year compared to not using components.
本研究旨在评估使用造口组件预防初次发生与渗漏相关的造口周围皮肤并发症(PSC)的个体后续PSC的经济和人文影响。
成本效用分析。
我们开发了一个简单的决策模型,从支付方的角度考虑在1年时间内使用和不使用造口组件管理PSC的情况。该模型评估了使用造口组件相关的结果(避免的PSC事件;获得的质量调整生命天数)在多大程度上抵消了其使用成本。
我们对1000名假设个体进行的为期1年的基础案例分析假设,在首次发生PSC后使用造口组件与不使用组件管理PSC相比,可减少复发事件。在此分析中,组件购置成本在很大程度上被造口用品(屏障;造口袋)资源使用的减少以及管理PSC的临床利用率降低所抵消。使用组件的个体每年的总体平均资源使用比不使用组件的个体高出约6.3%(139美元)。平均而言,每避免一次PSC事件在1年内可多获得8个质量调整生命天数。
在我们的分析中,(1)造口组件的购置成本全部或部分被用于管理PSC的造口用品使用量减少所抵消,并且(2)与不使用组件相比,使用造口组件预防PSC在1年内产生了更好的结果(更少的PSC重复事件;更多与健康相关的质量调整生命天数)。